MAZZONI, LUCA
 Distribuzione geografica
Continente #
EU - Europa 832
NA - Nord America 677
AS - Asia 98
AF - Africa 2
OC - Oceania 2
SA - Sud America 1
Totale 1.612
Nazione #
US - Stati Uniti d'America 677
PL - Polonia 532
RU - Federazione Russa 107
IT - Italia 82
IE - Irlanda 35
CN - Cina 28
SG - Singapore 25
SE - Svezia 20
HK - Hong Kong 17
GB - Regno Unito 11
JO - Giordania 10
VN - Vietnam 10
FR - Francia 9
BE - Belgio 7
FI - Finlandia 7
ES - Italia 6
ID - Indonesia 5
CH - Svizzera 3
IN - India 3
NL - Olanda 3
NO - Norvegia 3
AU - Australia 2
PT - Portogallo 2
AT - Austria 1
BR - Brasile 1
CI - Costa d'Avorio 1
DE - Germania 1
HU - Ungheria 1
LT - Lituania 1
UA - Ucraina 1
ZA - Sudafrica 1
Totale 1.612
Città #
Warsaw 532
Santa Clara 139
Fairfield 93
Woodbridge 50
Cambridge 46
Ann Arbor 41
Florence 38
Seattle 37
Wilmington 37
Dublin 35
Chandler 29
Houston 26
Ashburn 23
Singapore 20
Beijing 15
Hong Kong 12
Princeton 11
San Diego 11
Dong Ket 10
Altamura 9
Kent 9
Buffalo 8
Lawrence 8
Brussels 7
Barcelona 6
Jakarta 5
Medford 5
Milan 5
Boardman 4
Boston 4
Cagliari 4
Phoenix 4
Bern 3
Dearborn 3
Falls Church 3
Oslo 3
Shanghai 3
Andover 2
Castelliri 2
Jacksonville 2
London 2
Melbourne 2
Monza 2
Moscow 2
Mumbai 2
Norwalk 2
Prato 2
Siena 2
Abidjan 1
Amsterdam 1
Bremen 1
Brentford 1
Cape Town 1
Cedar Knolls 1
Foggia 1
Guangzhou 1
Helsinki 1
Iesi 1
Izsák 1
Jiaxing 1
Langfang 1
Naaldwijk 1
Redwood City 1
Rome 1
Rotterdam 1
Salerno 1
Serra 1
Sesto Fiorentino 1
São Paulo 1
Tappahannock 1
Vercurago 1
Verona 1
Vienna 1
Yubileyny 1
Totale 1.346
Nome #
Novel insights on the relationship between T-tubular defects and contractile dysfunction in a mouse model of hypertrophic cardiomyopathy. 339
Pathogenesis of hypertrophic cardiomyopathy is mutation rather than disease specific: A comparison of the cardiac troponin T E163R and R92Q mouse models 270
Regulation of intracellular Na+ in health and disease: pathophysiological mechanisms and implications for treatment 247
Late sodium current inhibitors to treat exercise induced obstruction in hypertrophic cardiomyopathy: an in vitro study in human myocardium. 218
Ranolazine prevents phenotype development in a mouse model of hypertrophic cardiomyopathy 145
IN VIVO AND IN VITRO ASSESSMENT OF PREVENTIVE EFFECTS OF RANOLAZINE ON PATHOLOGICAL PHENOTYPE IN TRANSGENIC MOUSE MODELS OF HYPERTROPHIC CARDIOMYOPATHY 143
UDP-glucose enhances outward K+currents necessary for cell differentiation and stimulates cell migration by activating the GPR17 receptor in oligodendrocyte precursors 136
R4496C RyR2 mutation impairs atrial and ventricular contractility 134
Totale 1.632
Categoria #
all - tutte 3.373
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.373


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020170 0 0 0 0 0 0 33 41 29 22 41 4
2020/2021272 30 26 4 34 15 24 21 17 17 61 12 11
2021/202287 4 3 14 4 3 1 9 2 2 9 18 18
2022/2023176 20 21 11 8 15 27 23 11 27 2 5 6
2023/202458 2 11 6 0 3 4 4 17 0 0 9 2
2024/2025318 17 37 29 57 115 63 0 0 0 0 0 0
Totale 1.632